30 results
8-K
EX-99.2
AORT
Artivion Inc
29 Mar 11
Entry into a Material Definitive Agreement
12:00am
Offerings – Surgical products for chronic cardiac ischemia
Leverage World Class Global Distribution Channel – Utilize CryoLife’s global sales channels … to 24) after close of transaction and expected to be fully integrated by beginning of 2012
Slide Twenty
Cardiogenesis Opportunity
Chronic ischemic
8-K
EX-99.1
AORT
Artivion Inc
15 Nov 11
Regulation FD Disclosure
12:00am
OF TISSUE]
Transmyocardial Revascularization (TMR)
Treatment for no-option patients with severe angina, incomplete revascularization and chronic
8-K
EX-99.1
AORT
Artivion Inc
29 Mar 11
Entry into a Material Definitive Agreement
12:00am
in the treatment of chronic myocardial ischemia. Cardiogenesis has been in discussions with the Food and Drug Administration (FDA) regarding initiating a randomized
424B1
2g3mx0ei lu
1 Apr 98
Prospectus with pricing info
12:00am